Scientists find interaction between amyloid and tau proteins that cause brain damage linked with AD
Rosa-Neto’s team analyzed the performances of 120 cognitively intact individuals over two years (equal gender distribution; average age 75). By measuring amyloid levels using PET scans and tau proteins through cerebrospinal fluid analysis, the researchers were able to identify the patients at risk of brain damage associated with AD. {read more here}
Previous research found a link between between the anticholinergic drugs and cognitive impairment and increased risk of dementia. The new paper published in the journal JAMA Neurology, is believed to be the first to study the potential underlying biology of those clinical links using neuroimaging measurements of brain metabolism and atrophy. {read more here}
Researchers in China have shown that adding measurements from computed bioconductance (CB) to fluorodeoxyglucose PET ( 18FDG-PET) imaging can work as a non-invasive, pre-biopsy option for accurately distinguishing between benign and malignant lesions in the lungs, according to a study abstract published ahead of presentation at an international thoracic specialist gathering. {read more here}
Using PET imaging to guide chemotherapy treatment significantly increases the number of people who go into remission and also decreases toxic side effects for people with advanced Hodgkin lymphoma, according to research conducted by SWOG and two other National Cancer Institute research groups. {read more here}